Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Apr-2026 | 473.9 | 499.95 | 473.9 | 496.45 | 7,171 | 8,16,87,094.2 | 82,680 |
02-Apr-2026 | 490 | 504 | 479.55 | 499.05 | 6,828 | 7,99,47,606.2 | 71,953 |
06-Apr-2026 | 496.3 | 498.75 | 482.6 | 493.35 | 4,740 | 5,89,97,228.65 | 47,612 |
07-Apr-2026 | 490.1 | 498.5 | 488 | 489.55 | 3,462 | 4,44,81,288.25 | 49,441 |
08-Apr-2026 | 496 | 515 | 495 | 504.9 | 6,038 | 10,63,63,515.35 | 1,08,257 |
09-Apr-2026 | 504 | 519.6 | 490.25 | 491.75 | 6,099 | 11,55,86,145.7 | 1,29,805 |
10-Apr-2026 | 495.6 | 519 | 495 | 515.95 | 10,196 | 13,37,85,611.95 | 1,32,178 |
13-Apr-2026 | 511.1 | 527.6 | 498.8 | 524.4 | 12,089 | 18,92,86,693.7 | 1,61,981 |
15-Apr-2026 | 531.95 | 554.95 | 528 | 545.3 | 18,647 | 34,03,38,073.5 | 3,19,000 |
16-Apr-2026 | 547.9 | 554.5 | 534.4 | 550.7 | 10,909 | 13,02,84,360.95 | 1,23,607 |
17-Apr-2026 | 550.5 | 557 | 544.15 | 545.75 | 5,324 | 7,95,84,270.8 | 69,468 |
20-Apr-2026 | 545.75 | 546.9 | 531.25 | 533.3 | 4,939 | 5,59,40,697.6 | 56,555 |
21-Apr-2026 | 533.3 | 539.5 | 532.05 | 534.3 | 6,320 | 4,17,22,701.1 | 43,238 |
22-Apr-2026 | 528.9 | 538.5 | 526.05 | 528.75 | 6,161 | 5,68,97,586.45 | 57,266 |
23-Apr-2026 | 526 | 547.45 | 526 | 539.5 | 6,720 | 9,36,21,944.85 | 88,009 |
24-Apr-2026 | 544.2 | 546.9 | 512.1 | 514.3 | 10,164 | 10,49,01,501.95 | 1,09,935 |
27-Apr-2026 | 525.9 | 532.7 | 513.9 | 531.3 | 7,173 | 8,29,43,265.6 | 82,050 |
28-Apr-2026 | 530 | 539.8 | 529.95 | 533.2 | 3,725 | 4,50,12,055.1 | 50,941 |
29-Apr-2026 | 531 | 550 | 527.85 | 543.7 | 8,436 | 8,45,85,885.95 | 97,334 |
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.
The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.
On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.
The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
